An experimental and molecular-modeling study of the binding of linked sulfated tetracyclitols to FGF-1 and FGF-2

被引:11
作者
Cochran, S [1 ]
Li, CP [1 ]
Bytheway, I [1 ]
机构
[1] Progen Ind Ltd, Drug Design Grp, Richlands BC, Qld 4077, Australia
关键词
angiogenesis; drug design; fibroblast growth factor; molecular modeling; surface plasmon resonance;
D O I
10.1002/cbic.200500089
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The experimental binding affinities of a series of linked sulfated tetracyclitols [Cyc(2)N-R-NCyc(2), where Cyc=C6H6(OSO3Na)(3) and R= (CH2)(n) (n=2-10), p-xylyl or (C2H4),-Ncyc] for the fibroblast growth factors FGF-1 and FGF-2 have been measured by using a surface plasmon resonance assay. The K, values range from 7.0 nM to 1.1 mu M for the alkyl-linked ligands. The binding affinity is independent of the flexibility of the linker, as replacement of the alkyl linker with a rigid p-xylyl group did not affect the K-D, Calculations suggest that binding modes for the p-xylyl-linked ligand are similar to those calculated for the flexible alkyl-linked tetracyclitols. The possible formation of cross-linked FGF:cyclitol complexes was examined by determining K-D values at increasing protein concentrations, No changes in K-D were observed; this suggesting that only 1:1 complexes are formed under these assay conditions. Monte. Carlo multiple-minima calculations of low-energy showed that all of the sulfated formers of the FGF-bound ligands showed tetracyclitol ligands. can bind effectively in the heparan. sulfate-binding sites of FGF-1, and FGF-2. Binding, affinities of these complexes were estimated by the Linear Interaction Energy (LIE) method to within a root-mean-square deviation of 1 kcal mol(-1) of the observed values. The effect of incorporating cations, to balance the overall charge of the complexes, during the, LIE calculations was also explored.
引用
收藏
页码:1882 / 1890
页数:9
相关论文
共 55 条
[51]   Binding constants of neuraminidase inhibitors: An investigation of the linear interaction energy method [J].
Wall, ID ;
Leach, AR ;
Salt, DW ;
Ford, MG ;
Essex, JW .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (25) :5142-5152
[52]   TUMOR-GROWTH DEPENDENT ON KAPOSIS SARCOMA-DERIVED FIBROBLAST GROWTH-FACTOR INHIBITED BY PENTOSAN POLYSULFATE [J].
WELLSTEIN, A ;
ZUGMAIER, G ;
CALIFANO, JA ;
KERN, F ;
PAIK, SM ;
LIPPMAN, ME .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (10) :716-720
[53]   Identification of inhibitors of heparin-growth factor interactions from combinatorial libraries of four-component condensation reactions [J].
Zhang, JD ;
Rivers, G ;
Zhu, YY ;
Jacobsen, A ;
Peyers, J ;
Grundstrom, G ;
Burch, P ;
Hussein, S ;
Marolewski, A ;
Herlihy, W ;
Rusche, J .
BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (04) :825-836
[54]   New linear interaction method for binding affinity calculations using a continuum solvent model [J].
Zhou, RH ;
Friesner, RA ;
Ghosh, A ;
Rizzo, RC ;
Jorgensen, WL ;
Levy, RM .
JOURNAL OF PHYSICAL CHEMISTRY B, 2001, 105 (42) :10388-10397
[55]   STRUCTURAL STUDIES OF THE BINDING OF THE ANTIULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH-FACTOR [J].
ZHU, XT ;
HSU, BT ;
REES, DC .
STRUCTURE, 1993, 1 (01) :27-34